Literature DB >> 18848913

Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells.

Naomi Walsh1, Paul Dowling, Norma O'Donovan, Michael Henry, Paula Meleady, Martin Clynes.   

Abstract

Conditioned medium (CM) from clonal sub-populations of the pancreatic cancer cell line, MiaPaCa-2 with differing invasive abilities, were examined for their effect on in vitro invasion. Conditioned medium from Clone #3 (CM#3) strongly promoted invasion, while CM from Clone #8 (CM#8) inhibited invasion in vitro. 2D DIGE followed by MALDI-TOF MS analysis of CM#3 and CM#8 identified 41 proteins which were differentially regulated; 27 proteins were down-regulated and 14 proteins up-regulated in the invasion-promoting CM#3 when compared to CM#8. Western blotting analysis confirmed the down-regulated expression of gelsolin and the up-regulation of aldehyde dehydrogenase 1A1 in CM#3. Down-regulation of aldehyde dehydrogenase 1A1 in Clone #3 CM and gelsolin levels in Clone #8 CM by siRNA transfection revealed an important involvement of these proteins in promoting and inhibiting invasion in these pancreatic cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848913     DOI: 10.1016/j.jprot.2008.09.002

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  9 in total

1.  Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival.

Authors:  Yin Lv; Lin Yang; Fan Wang
Journal:  Med Oncol       Date:  2015-04-03       Impact factor: 3.064

Review 2.  New promising drug targets in cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2010-03-23       Impact factor: 7.851

3.  Force-induced myofibroblast differentiation through collagen receptors is dependent on mammalian diaphanous (mDia).

Authors:  Matthew W C Chan; Faiza Chaudary; Wilson Lee; John W Copeland; Christopher A McCulloch
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

4.  Proteomic characterization of Her2/neu-overexpressing breast cancer cells.

Authors:  Hexin Chen; Genaro Pimienta; Yiben Gu; Xu Sun; Jianjun Hu; Min-Sik Kim; Raghothama Chaerkady; Marjan Gucek; Robert N Cole; Saraswati Sukumar; Akhilesh Pandey
Journal:  Proteomics       Date:  2010-11       Impact factor: 3.984

5.  Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis.

Authors:  Parveen Sharma; Thiruchelvi Shathasivam; Vladimir Ignatchenko; Thomas Kislinger; Anthony O Gramolini
Journal:  Mol Biosyst       Date:  2011-01-18

6.  7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells.

Authors:  Dermot O'Sullivan; Michael Henry; Helena Joyce; Naomi Walsh; Edel Mc Auley; Paul Dowling; Niall Swan; Michael Moriarty; Paul Barnham; Martin Clynes; Annemarie Larkin
Journal:  Tumour Biol       Date:  2014-04-18

7.  Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.

Authors:  Jin Cheon Kim; Ye Jin Ha; Ka Hee Tak; Seon Ae Roh; Chan Wook Kim; Tae Won Kim; Seon-Kyu Kim; Seon-Young Kim; Dong-Hyung Cho; Yong Sung Kim
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

8.  Connecting myelin-related and synaptic dysfunction in schizophrenia with SNP-rich gene expression hubs.

Authors:  Hedi Hegyi
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

9.  A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.

Authors:  Dermot O'Sullivan; Paul Dowling; Helena Joyce; Edel McAuley; Andrew McCann; Michael Henry; Brianan McGovern; Paul Barham; Fergal C Kelleher; Jean Murphy; Susan Kennedy; Niall Swan; Michael Moriarty; Martin Clynes; Annemarie Larkin
Journal:  Br J Cancer       Date:  2017-09-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.